Hormonal Contraceptives Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Hormonal Contraceptive Market is segmented by Product (Oral Contraceptives, Skin Patches, Intrauterine Devices, Hormonal Implants, and Others), Hormone (Progestin Only and Combined Hormone Contraceptives), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Hormonal Contraceptives Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Hormonal Contraceptives Industry Overview

The hormonal contraceptives market is fragmented in nature due to the presence of a few companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known. The key market players are Allergan plc, Afaxys, Inc., Merck & Co., Inc., Pfizer Inc., Viatris Inc (Mylan N.V.), Bayer AG, Agile Therapeutics, Novartis AG, Johnson & Johnson Private Limited, and Piramal Enterprises Ltd. among others.

Hormonal Contraceptives Market Leaders

  1. Allergan plc

  2. Afaxys, Inc.

  3. Merck & Co., Inc.

  4. Pfizer Inc.

  5. Mylan N.V.

  6. *Disclaimer: Major Players sorted in no particular order
Picture2.png

Global Hormonal Contraceptives Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?